United Kingdom

People: Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

18 Apr 2019
Change (% chg)

$-0.40 (-4.07%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

van Heek, Christine 

Ms. Christine van Heek is an Independent Director of Concert Pharmaceuticals Inc. Ms. van Heek has served as an advisor and consultant to several companies on global commercialization, sales, marketing and business development in the biotechnology and pharmaceutical industry. From 1991 to 2003, Ms. van Heek served in various roles at Genzyme Corporation, including Corporate Officer and President, Therapeutics Division, where she was responsible for building worldwide commercialization organizations and sales and marketing management. Under her leadership, the division expanded into over 60 countries and annual revenues grew to $700 million. In addition, she has held various sales and marketing positions at Genentech, Inc. and Caremark/HHCA. Ms van Heek served on the board of directors of Affymax, Inc. from 2007-2014. Ms. van Heek currently serves on the Board of Directors for Visioneering Technologies, Inc. She holds a B.S.N. from the University of Iowa and received her M.B.A. from Lindenwood University in St. Louis and a B.S.N. from the University of Iowa. We believe that Ms. van Heek's industry experience, including her extensive experience in strategic roles of a publicly traded biomaterials company, make her a key contributor to our Board of Directors.

Basic Compensation

Total Annual Compensation, USD 45,220
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 90,720
Fiscal Year Total, USD 135,940

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Aldrich


Roger Tung


Marc Becker


Nancy Stuart


Lynette Herscha


James Cassella,

As Of  31 Dec 2017